N-(Mal)-N-(PEG8-Val-Cit-PAB-MMAE)-N-(PEG8-Val-Cit-PAB-Exatecan)
PG-20161-12336
MW 2945.5
Same subcategory
PG-20161-57335
Missing values are marked “Not specified”. Request the technical information you need with your inquiry. For research use only.
| Catalog No. | Packaging | Price (USD) | Stock | Inquiry action |
|---|---|---|---|---|
| PG-20161-57335 | 1 MG | Inquiry | In stock | |
| PG-20161-57335 | 5 MG | Inquiry | In stock | |
| PG-20161-57335 | 10 MG | Inquiry | In stock | |
| PG-20161-57335 | 25 MG | Inquiry | In stock |
Final pricing, package availability and delivery are confirmed with your quotation.
Mal-PEG12-Val-Cit-PAB-Exatecan is a cleavable linker-payload for antibody-drug conjugate research. It combines an exatecan payload with a Val-Cit-PAB segment, a PEG12 chain and a maleimide group. The Val-Cit dipeptide is susceptible to Cathepsin B cleavage, while the maleimide supports conjugation to thiol-containing biomolecules. The PEG12 chain contributes hydrophilicity. Listed solvents are Water, DMF, and the supplied purity is 95%.